<DOC>
	<DOCNO>NCT01891578</DOCNO>
	<brief_summary>Evaluation immunological reconstitution haploidentical BMT use nonmyeloablative preparative regimen post-transplant cyclophosphamide patient poor prognosis lymphoma</brief_summary>
	<brief_title>Evaluation Immunological Reconstitution After Haploidentical Bone Marrow Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<criteria>Patients lymphoma ( histology ) relapse high dose chemotherapy partial remission , complete remission stable disease last CT line Signed informed consent perform haploidentical alloBMT use nonmyeloablative preparative regimen posttransplant cyclophosphamide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>